Regarding the functional analysis of primary BC, so far, the most promising approach is immunofluorescence microscopy of RAD51 in S-phase nuclei of tumor slices ex vivo, which provides a biomarker for the response to PARP inhibitory drugs with superior predictive value as compared to a genomic signature correlating with HR-deficiency [150]. This evidence concerns the gene PARP1 and breast cancer.